Folvite

Folic Acid Deficiency, Postpartum state, Folic Acid Deficiency + 7 more
Treatment
20 Active Studies for Folvite

What is Folvite

Folic acidThe Generic name of this drug
Treatment SummaryFolic acid, also known as folate or Vitamin B9, is an essential nutrient for the body. It helps with the production of DNA and RNA and is necessary for cell division. As people cannot produce folic acid on their own, it must be obtained from food sources such as green vegetables, beans, avocado, and some fruits. Folic acid is especially important for pregnant women to help prevent neural tube defects in newborns. It can also be supplemented to individuals using certain medications, such as antiepileptic drugs. Insufficient levels of folic acid can lead to cardiovascular disease, anemia, cognitive deficiencies, and
O-Cal FA multivitaminis the brand name
image of different drug pills on a surface
Folvite Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
O-Cal FA multivitamin
Folic acid
1970
151

Effectiveness

How Folvite Affects PatientsFolic acid, also known as Vitamin B9 or folate, is an important vitamin found in foods like liver, kidney, and leafy green vegetables. It is necessary for the body to build and repair DNA and RNA, as well as to produce proteins. Folic acid is especially important in times of rapid cell division such as infancy, pregnancy, and erythropoiesis, and can help protect against cancer. Humans are not able to produce folic acid on their own, so it needs to be taken from food or supplements. In order for folic acid to work in the body, it is reduced by an enzyme
How Folvite works in the bodyFolic acid helps the body in many different ways. To do this, it needs to be converted into active forms like tetrahydrofolic acid and methyltetrahydrofolate. These active forms are then transported into cells and used to synthesize important molecules like purines and thymidylate nucleic acids. Folic acid also helps the body convert homocysteine into methionine, which can help reduce high levels of homocysteine. Vitamin B12 is needed to help folic acid do this.

When to interrupt dosage

The measure of Folvite is contingent upon the diagnosed condition, including Pregnancy, Iron deficiency anemia and Iron deficiency. The measure fluctuates as per the method of delivery featured in the table beneath.
Condition
Dosage
Administration
Postpartum state
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Nutritional supplementation
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Iron deficiency
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Folic Acid Deficiency
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
methotrexate toxicity
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Anemia, Iron-Deficiency
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Folic Acid Deficiency
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Iron Deficiency Anemia
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
N-Cadherins
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch
Avitaminosis
, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg
, Oral, Powder - Oral, Capsule, Capsule - Oral, Capsule, gelatin coated, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Kit, Injection, solution, Injection, solution - Intravenous, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, Powder, for solution, Pill - Oral, Capsule, liquid filled - Oral, Kit - Oral, Lozenge - Oral, Intravenous, Liquid, Lozenge, Liquid - Intravenous, Powder, Solution / drops, Tablet, extended release, Liquid - Oral, Tablet, chewable, Liquid - Intramuscular; Intravenous; Subcutaneous, Tablet, Delayed Release, Wafer - Oral, Tablet, effervescent, Granule, effervescent, Tablet, extended release - Oral, Powder, for solution - Oral, Intramuscular; Intravenous; Subcutaneous, Granule, effervescent - Oral, Tablet, effervescent - Oral, Solution, Transdermal, Solution / drops - Oral, Strip, Strip - Oral, Solution - Intramuscular; Intravenous; Subcutaneous, Capsule, coated - Oral, Capsule, coated, Injection, Injection - Intravenous, Solution - Intravenous, Patch - Transdermal, Capsule, extended release, Bar, chewable, Bar, chewable - Oral, Capsule, extended release - Oral, Solution - Oral, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Wafer, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Capsule, delayed release pellets - Oral, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Tablet - Sublingual, Sublingual, Tablet, Delayed Release - Oral, Solution - Parenteral, Parenteral, Capsule, delayed release pellets, Pill, Patch

Warnings

There are 20 known major drug interactions with Folvite.
Common Folvite Drug Interactions
Drug Name
Risk Level
Description
5-fluorouridine
Major
The risk or severity of adverse effects can be increased when Folic acid is combined with 5-fluorouridine.
Capecitabine
Major
The risk or severity of adverse effects can be increased when Folic acid is combined with Capecitabine.
Doxifluridine
Major
The risk or severity of adverse effects can be increased when Folic acid is combined with Doxifluridine.
Flucytosine
Major
The risk or severity of adverse effects can be increased when Folic acid is combined with Flucytosine.
Fluorouracil
Major
The risk or severity of adverse effects can be increased when Folic acid is combined with Fluorouracil.
Folvite Toxicity & Overdose RiskThe lowest toxic dose of IPR-MUS in rats is 85mg/kg, IVN-GPG is 120mg/kg, IVN-MUS is 239mg/kg, IVN-RAT is 500mg/kg, and IVN-RBT is 410mg/kg.

Folvite Novel Uses: Which Conditions Have a Clinical Trial Featuring Folvite?

76 active studies are being conducted to assess the potential of Folvite in managing Iron deficiency anemia, Pregnancy and Postpartum states.
Condition
Clinical Trials
Trial Phases
Nutritional supplementation
0 Actively Recruiting
Folic Acid Deficiency
0 Actively Recruiting
Postpartum state
11 Actively Recruiting
Not Applicable, Phase 4, Phase 1
N-Cadherins
0 Actively Recruiting
Avitaminosis
1 Actively Recruiting
Not Applicable
Anemia, Iron-Deficiency
0 Actively Recruiting
Folic Acid Deficiency
0 Actively Recruiting
methotrexate toxicity
0 Actively Recruiting
Iron deficiency
6 Actively Recruiting
Phase 2, Not Applicable, Phase 4, Early Phase 1, Phase 3
Iron Deficiency Anemia
7 Actively Recruiting
Phase 3, Phase 4, Phase 2, Not Applicable

Patient Q&A Section about folvite

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Folvite a vitamin Tablet?

"Folvite is a vitamin that is available both over the counter and by prescription. It is used as a nutritional supplement to prevent Neural Tube Defects and Folic Acid deficiency, and as a treatment for methanol toxicity. Folvite can be used alone or with other medications."

Answered by AI

What is Folvite used for?

"Folic acid supplements are taken to treat or prevent low folate levels, which can lead to anemia. Low folate levels can be caused by conditions such as poor diet, pregnancy, alcoholism, liver disease, and certain stomach/intestinal problems."

Answered by AI

When should Folvite be taken?

"Folvite 5mg Tablet can be taken at any time of day, but it is best to take it at the same time each day to help remember. Take as prescribed by your doctor. Swallow the medicine whole with a glass of water."

Answered by AI

What is the difference between folic acid and Folvite?

"Folate is a natural form of vitamin B9 found in food, while folic acid is a synthetic form. High intake of folic acid can lead to increased blood levels of unmetabolized folic acid."

Answered by AI

Clinical Trials for Folvite

Image of University of California San Diego in La Jolla, United States.

AI Chatbot for Postpartum Loneliness

18+
Female
La Jolla, CA
The goal of this clinical trial is to learn whether a postpartum chatbot powered by generative artificial intelligence (genAI) can help new mothers get better pelvic floor health information and feel less lonely after childbirth. The main questions this study aims to answer are: * Does using the chatbot improve postpartum pelvic floor health knowledge? * Does using the chatbot help reduce feelings of loneliness during the postpartum period? * Does using the chatbot impact pelvic floor symptoms? Researchers will compare standard postpartum care to standard care plus the chatbot. Participants will: Be assigned by chance (like flipping a coin) to standard postpartum care with or without access to the chatbot. If in the chatbot group, participants will receive education and support via the chatbot over a 4-week period. Both groups will complete questionnaires to measure their pelvic floor knowledge, pelvic floor symptoms, feelings of loneliness, depression, infant bonding, perceived social support, adverse childhood experiences, and peri-traumatic distress. The chatbot was created by urogynecology experts in collaboration with UC San Diego computer science and biomedical informatics researchers. The chatbot is designed to give new mothers personalized, evidence-based information and support in real time.
Waitlist Available
Has No Placebo
University of California San Diego
Image of Columbia University Irving Medical Center in New York, United States.

Intravenous Iron for Iron Deficiency in Scoliosis

10 - 19
All Sexes
New York, NY
Adolescents and young adults undergoing spinal fusion surgery for the correction of scoliosis and other spinal deformity are at high risk of perioperative iron deficiency and anemia, yet the means and evidence for optimizing iron status have not been described in this setting. The proposed study is a randomized controlled trial of preoperative intravenous iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in this vulnerable population. Building evidence for patient blood management interventions such as iron supplementation is vital to ensuring high quality care of surgical patients and may reduce unnecessary transfusions amid recent blood shortages.
Phase 2 & 3
Waitlist Available
Columbia University Irving Medical Center
Image of Madigan Army Medical Center in Tacoma, United States.

Vitamin D3 + K2 for Vitamin Deficiency

18 - 69
All Sexes
Tacoma, WA
The main purpose of this research study is to learn about the effects of supplemental vitamin D3 and vitamin K2 on blood levels and the gut microbial community, called the gut microbiome. There are many influences on blood levels of vitamin D and K to include your dietary intake, lifestyle behaviors (physical activity, sleep), genetic alterations in metabolism of these vitamins, and the gut microbial abundance and diversity. You will be asked to take one capsule containing vitamin D3 (125 mcg), vitamin K2 (180 mcg), a combination of vitamins D3 and K2 (same doses as previous), or a placebo powder for 90 days. You will also be asked to complete questionnaires, undergo body composition and blood pressure measurements, provide blood samples and a stool swab, all on 2 occasions about 3 - 4 months apart. By conducting this study, we aim to identify the frequency of common genetic alterations in vitamins D and K metabolism and establish the impact on the gut microbiome for the first time. Your participation in this study will last about 4 - 6 months and include up to 3 visits.
Recruiting
Paid Trial
Madigan Army Medical CenterMary S McCarthy, PhD
Have you considered Folvite clinical trials? We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.Go to Trials
Image of University of Calgary in Calgary, Canada.

Iron Supplementation for Iron Deficiency

18 - 40
Female
Calgary, Canada
The goal of this clinical trial is to learn whether oral iron supplementation will increase skeletal muscle iron storage and its effects on exercise capacity in females with suboptimal iron status. The study will include healthy females, ages 18-40, who either have suboptimal or optimal iron stores. The main questions it aims to answer are: * Does iron supplementation increase skeletal muscle iron storage and alter the expression of iron-related and mitochondrial proteins? * Does iron supplementation improve single-leg exercise performance? * Is serum ferritin correlated with the abundance of iron-related proteins in skeletal muscle? Researchers will compare outcomes from females with suboptimal iron status who receive oral iron supplementation to those who receive a placebo to see if supplementation improves muscle iron storage, protein expression, and exercise performance. Additionally, a non-intervention control group with optimal iron status will be included to assess baseline differences. Participants will: \- Be randomly assigned to receive 150 mg elemental iron or placebo (maltodextrin) every other day for 12 weeks Complete pre- and post-supplementation testing, including: * Blood draws to assess iron status * Skeletal muscle biopsies to analyze protein content * Whole-body and single-leg exercise tests to assess performance * Controls will undergo baseline-only testing to compare physiological and biochemical markers
Phase < 1
Waitlist Available
University of CalgaryMartin J MacInnis
Image of Women's College Hospital in Toronto, Canada.

MOVIN Care Platform for Postpartum Depression

18+
Female
Toronto, Canada
Depression, anxiety, and related disorders such as post-traumatic stress and obsessive compulsive disorder affect about 20% of pregnant and postpartum people. When not treated properly, these issues negatively impact not only affected people, but also their children's health and development. Only 1 in 5 receive adequate treatment, so identifying new system-wide approaches to reliably deliver recommended care to perinatal mental health patients all is a crucial health care priority. The Pregnancy and Postpartum Mental health Optimization Virtual Intervention Network (MOVIN) is a scalable perinatal mental health platform building on the evidence-based Collaborative care delivery model. MOVIN's online platform allows patients to connect with a care coordinator to co-develop personalized treatment recommendations, in collaboration with their primary care clinician and a perinatal psychiatrist when needed; progress is tracked to re-evaluate.
Recruiting
Has No Placebo
Women's College Hospital
Image of The Medical Center in Bowling Green, United States.

Iron Supplementation for Heart Failure

18 - 100
All Sexes
Bowling Green, KY
The goal of this clinical trial is to learn which iron treatment works better for adults with congestive heart failure and low iron levels: intravenous (IV) iron given through a vein or oral (PO) iron taken by mouth. Participants must have heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF) and a transferrin-saturation (TSAT) level below 20 percent. The main questions the study will answer are: 1. Does IV iron raise walking distance on a 6-minute walk test more than oral iron after 24 weeks? 2. Does IV iron improve symptoms and quality of life more than oral iron? 3. How do the two treatments compare for safety, side effects, and hospital readmissions/ mortality? Researchers will compare IV ferric carboxymaltose with oral ferrous sulfate to see which option helps people feel and function better. What participants will do * Be randomly assigned by (like flipping a coin) to IV iron or oral iron. * Receive either a one-time IV iron infusion (with possible repeat at 12 weeks) or take iron pills twice each day for 24 weeks. * Visit the infusion clinic at 6 weeks for second dose of IV iron if needed. * Visit the clinic at 12 weeks for a follow-up to gather follow-up data including 1. A 6-minute walk test 2. Brief symptom and quality-of-life surveys 3. Blood tests to measure serum iron, ferritin, and transferrin saturation This study will help doctors decide whether IV or oral iron is the safer, more effective way to treat iron deficiency in people with heart failure in our local community.
Phase 4
Recruiting
The Medical CenterAmerican Regent, Inc.
Have you considered Folvite clinical trials? We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.Go to Trials
Image of Stone Hall in West Lafayette, United States.

Iron Supplementation for Menorrhagia

18+
Female
West Lafayette, IN
The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are: * What is the association between iron status, cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? * How does iron repletion, via supplementation, affect cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women? The investigators will compare the effect of iron supplements to a placebo (gelatin capsule) to see if iron supplements could improve iron status, cognitive function, mood, quality of family relationships, and quality of life of iron-deficient and/or anemic women undergoing the menopausal transition. Each participant will: * Make 2 visits (about 2 hours each - baseline and endline) to the Clinical Research Center at Purdue * Make a very brief visit at midpoint (about 10 minutes) for a checkup * Take a daily study supplement or placebo for 4 months
Waitlist Available
Paid Trial
Stone HallLaura E Murray-Kolb, PhD
Image of Massachusetts General Hospital in Boston, United States.

Facilitated Transition to Primary Care for Postpartum

18+
Female
Boston, MA
The lack of postpartum primary care coordination is a missed opportunity to increase primary care engagement and manage chronic conditions early in life, especially for the \>30% of pregnant people who have or are at risk for these conditions. This study aims to increase postpartum primary care engagement, quality, and experience by strengthening postpartum transitions to primary care using a behavioral economics-informed, multi-component intervention integrated into usual inpatient postpartum care. Using a randomized controlled trial and repeated outcome assessments through administrative and survey data, this study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice, potentially catalyzing sustained primary care engagement throughout life.
Recruiting
Has No Placebo
Massachusetts General HospitalMark A Clapp, MD, MPH
Have you considered Folvite clinical trials? We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security